The table below shows ABEONA THERAPEUTICS INC.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q1 2025
Q1 2024
Q1 2023
Q1 2022
Q1 2021
Operating cash flow
-$19.80M
-$18.40M
-$14.54M
-$11.74M
-$13.69M
-$13.59M
Capital expenditure
$935.00K
$1.40M
$725.00K
$218.00K
$103.00K
$444.00K
Investing cash flow
$4.96M
$4.21M
-$7.82M
$2.21M
$1.07M
$9.38M
Dividends paid
-
-
-
-
ABEO operating cash flow (10-K history)
ABEONA THERAPEUTICS INC. reported operating cash flow of -$76.33M for fiscal year 2025. That is down 36.3% from -$56.02M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow declined from -$13.01M (FY 2016) to -$76.33M. Figures come from the company's audited annual reports as filed with the SEC.